{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:23:08Z","timestamp":1792264988911,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2009957"],"award-info":[{"award-number":["2009957"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1004455"],"award-info":[{"award-number":["1004455"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.molimm.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T03:37:24Z","timestamp":1739158644000},"page":"84-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Peripheral and central elevation of IL-8 in patients with Huntington\u2019s disease"],"prefix":"10.1016","volume":"179","author":[{"given":"Jenny N.","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-911X","authenticated-orcid":false,"given":"Trent M.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","article-title":"Single-nucleus RNA-seq identifies Huntington disease astrocyte states","volume":"8","author":"Al-Dalahmah","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.molimm.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"Alvarez-Luquin","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.molimm.2025.02.003_bib3","article-title":"Huntington's disease: a clinical review","volume":"14","author":"Andhale","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.molimm.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-8993(00)03176-0","article-title":"Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology","volume":"894","author":"Apelt","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.molimm.2025.02.003_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nri.2016.123","article-title":"Cytokine networks in neuroinflammation","volume":"17","author":"Becher","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mds.26950","article-title":"Disease stage and plasma levels of cytokines in Huntington's disease: a 2-year follow-up study","volume":"32","author":"Bouwens","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2025.02.003_bib8","doi-asserted-by":"crossref","first-page":"1272118","DOI":"10.3389\/fragi.2023.1272118","article-title":"Sex and gender affect immune aging","volume":"4","author":"Calabro","year":"2023","journal-title":"Front Aging"},{"key":"10.1016\/j.molimm.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molimm.2025.02.003_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.molimm.2025.02.003_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.566922","article-title":"Interleukin-17A: the key cytokine in neurodegenerative diseases","volume":"12","author":"Chen","year":"2020","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.molimm.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2025.02.003_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.0000000000002944","article-title":"Clinical manifestations of intermediate allele carriers in Huntington disease","volume":"87","author":"Cubo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2025.02.003_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib16","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000603","article-title":"Effect of body weight on age at onset in huntington disease: a mendelian randomization study","volume":"7","author":"van der Burg","year":"2021","journal-title":"Neurol. Genet"},{"key":"10.1016\/j.molimm.2025.02.003_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-019-1453-0","article-title":"Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease","volume":"16","author":"Dionisio-Santos","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.molimm.2025.02.003_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cmi.2017.02.013","article-title":"Body mass index and the risk of infection - from underweight to obesity","volume":"24","author":"Dobner","year":"2018","journal-title":"Clin. Microbiol Infect."},{"key":"10.1016\/j.molimm.2025.02.003_bib19","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington's disease","volume":"11","author":"Du","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet"},{"key":"10.1016\/j.molimm.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.25647","article-title":"Early intrathecal T Helper 17.1 cell activity in Huntington disease","volume":"87","author":"von Essen","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","article-title":"The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A","volume":"19","author":"Fu","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.molimm.2025.02.003_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2025.02.003_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mdc3.13178","article-title":"Sex differences in Huntington's disease: evaluating the enroll-HD database","volume":"8","author":"Hentosh","year":"2021","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.molimm.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","article-title":"Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner","volume":"34","author":"Huber","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2025.02.003_bib26","doi-asserted-by":"crossref","first-page":"1088124","DOI":"10.3389\/fimmu.2022.1088124","article-title":"Neuroinflammation in Huntington's disease: from animal models to clinical therapeutics","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.09.001","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease","volume":"135","author":"Kong","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molimm.2025.02.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105199","article-title":"An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease","volume":"148","author":"Kong","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molimm.2025.02.003_bib30","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI64484","article-title":"Mutant huntingtin impairs immune cell migration in Huntington disease","volume":"122","author":"Kwan","year":"2012","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2025.02.003_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160295","article-title":"Correction: RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"11","author":"Labadorf","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.02.003_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","article-title":"Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial rna release and neuronal innate immune activation","volume":"107","author":"Lee","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.molimm.2025.02.003_bib33","first-page":"1173","article-title":"Oral treatment with herbal formula B307 alleviates cardiac failure in aging R6\/2 mice with Huntington's disease via suppressing oxidative stress, inflammation, and apoptosis","volume":"10","author":"Lin","year":"2015","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.molimm.2025.02.003_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the immune response in the brain: IL-10 and its regulation","volume":"13","author":"Lobo-Silva","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.molimm.2025.02.003_bib35","first-page":"452","article-title":"Rate of functional decline in Huntington's disease","volume":"54","author":"Marder","year":"2000","journal-title":"Huntingt. Study Group. Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41467-022-35752-x","article-title":"Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington's disease","volume":"14","author":"Matsushima","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2025.02.003_bib37","doi-asserted-by":"crossref","first-page":"e2395","DOI":"10.1212\/WNL.0000000000011893","article-title":"Timing and impact of psychiatric, cognitive, and motor abnormalities in Huntington disease","volume":"96","author":"McAllister","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2025.02.003_bib38","first-page":"2893","article-title":"RNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation","volume":"25","author":"Miller","year":"2016","journal-title":"Hum. Mol. Genet"},{"issue":"8","key":"10.1016\/j.molimm.2025.02.003_bib39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"Moller","year":"2010","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.molimm.2025.02.003_bib40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib41","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.4049\/jimmunol.0900305","article-title":"Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer","volume":"183","author":"Nasser","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16106","article-title":"Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases","author":"Netzahualcoyotzi","year":"2024","journal-title":"J. Neurochem"},{"key":"10.1016\/j.molimm.2025.02.003_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-014-0060-2","article-title":"A common gene expression signature in Huntington's disease patient brain regions","volume":"7","author":"Neueder","year":"2014","journal-title":"BMC Med Genom."},{"key":"10.1016\/j.molimm.2025.02.003_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","article-title":"Ubiquitin-proteasome system involvement in Huntington's disease","volume":"7","author":"Ortega","year":"2014","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.molimm.2025.02.003_bib45","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2025.02.003_bib46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib47","article-title":"Behavioral- and blood-based biomarkers for Huntington's disease: studies on the R6\/1 mouse model with prospects for early diagnosis and monitoring of the disease","volume":"23","author":"Podlacha","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.molimm.2025.02.003_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.molimm.2025.02.003_bib49","article-title":"Multi-omics analysis reveals key gut microbiota and metabolites closely associated with Huntington's disease","author":"Qian","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molimm.2025.02.003_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0404.2008.01103.x","article-title":"Circulating interleukin-10 and interleukin-12 in Parkinson's disease","volume":"119","author":"Rentzos","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.molimm.2025.02.003_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12079-022-00686-y","article-title":"A comprehensive network map of IL-17A signaling pathway","volume":"17","author":"Rex","year":"2023","journal-title":"J. Cell Commun. Signal"},{"key":"10.1016\/j.molimm.2025.02.003_bib52","doi-asserted-by":"crossref","first-page":"1384480","DOI":"10.3389\/fneur.2024.1384480","article-title":"Sex differences in Huntington's disease from a neuroinflammation perspective","volume":"15","author":"Risby-Jones","year":"2024","journal-title":"Front Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib53","doi-asserted-by":"crossref","first-page":"8653132","DOI":"10.1155\/2016\/8653132","article-title":"Neuroimmunology of Huntington's disease: revisiting evidence from human studies","volume":"2016","author":"Rocha","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molimm.2025.02.003_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2025.02.003_bib56","unstructured":"Shoulson I., K.R., Rubin A. Assessment of functional capacity in neurodegenerative disorders: Huntington's disease as a prototype. In: Munsat TL, ed. Quantification of Neurologic Deficits. 285\u2013309 (Butterworth, Boston, 1989)."},{"key":"10.1016\/j.molimm.2025.02.003_bib57","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.molimm.2025.02.003_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578243","article-title":"Circulating levels of inflammatory biomarkers in Huntington's disease: a systematic review and meta-analysis","volume":"385","author":"Soltani Khaboushan","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib60","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.molimm.2025.02.003_bib61","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","article-title":"Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability","volume":"25","author":"Stamatovic","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.molimm.2025.02.003_bib62","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib64","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"A biological classification of Huntington's disease: the Integrated Staging System","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2025.02.003_bib65","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.molimm.2025.02.003_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","article-title":"Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline","volume":"76","author":"Taipa","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molimm.2025.02.003_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.molimm.2025.02.003_bib68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington's disease immune dysfunction caused by NFkappaB pathway dysregulation","volume":"137","author":"Trager","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.molimm.2025.02.003_bib69","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2014.10.012","article-title":"Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models","volume":"73","author":"Trager","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molimm.2025.02.003_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2016.02.012","article-title":"Revelation of the IFNalpha, IL-10, IL-8 and IL-1beta as promising biomarkers reflecting immuno-pathological mechanisms in porcine Huntington's disease model","volume":"293","author":"Valekova","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147813","article-title":"Modelling the human blood-brain barrier in Huntington disease","volume":"23","author":"Vignone","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.molimm.2025.02.003_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-020-00379-3","article-title":"Interleukin-6 deficiency exacerbates Huntington's disease model phenotypes","volume":"15","author":"Wertz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.molimm.2025.02.003_bib73","doi-asserted-by":"crossref","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington's disease","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.molimm.2025.02.003_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnagi.2017.00193","article-title":"Microglial activation in the pathogenesis of Huntington's disease","volume":"9","author":"Yang","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.molimm.2025.02.003_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5114\/ceji.2015.56961","article-title":"Matrine improves cognitive impairment and modulates the balance of Th17\/Treg cytokines in a rat model of Abeta1-42-induced Alzheimer's disease","volume":"40","author":"Zhang","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2025.02.003_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fmed.2020.00079","article-title":"Prevalence of non-psychiatric comorbidities in pre-symptomatic and symptomatic Huntington's disease gene carriers in Poland","volume":"7","author":"Zielonka","year":"2020","journal-title":"Front Med (Lausanne)"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:38:18Z","timestamp":1740674298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":76,"alternative-id":["S0161589025000276"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.02.003","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral and central elevation of IL-8 in patients with Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}